View our training and events calendar

Learn More

Publication Review: Amin Analysis on Impella and IABP

Review of Trends, Variation and Outcomes in Impella® Use Dr. Seth Bilazarian, Abiomed’s Chief Medical Offi...

Clinical Paper: Beyond Reperfusion by Jerry Curran

Acute Ventricular Unloading and Cardioprotection During MI Jerry Curran PhD, Senior Scientist at Abio...

Impella Support Pre-PCI for AMICS is Associated with Higher Survival in Women

Reference: J Interven Cardiol 2016; 29:248–256. Ca...

PCI vs CABG in Patients with Unprotected Left Main Coronary Artery Disease

Key TakeawaysThis meta-analysis evaluated 6 randomized controlled trials to determin...

The Campeau Radial Paradox: Radial vs. Femoral Access [JACC]

A 2015 paper on the Campeau Radial Paradox in...

2015 Consensus Recommendations on Percutaneous Mechanical Circulatory Support Devices

The availability of percutaneous mechanical support (MCS) devices such as Impella®, TandemHeart, and ECMO requires cardiologis...

Study Finds pVADs are Cost-Effective for High-Risk PCI

In the era of increasing healthcare costs, the cost-effectiveness of traditional versus emerging technologies is an ongoing con...

Circulation Editorial Discusses Advances in High-Risk PCI

A recent editorial by Dr. Ted Bass from the University of Florida published in...

High-Risk Percutaneous Coronary Interventions in Modern Day Clinical Practice: Current Concepts and Challenges

The advances of the percutaneous coronary intervention (PCI) procedure has evolved significantly since the early 1980’s, acco...

Latest Appropriate Use Criteria for Coronary Revascularization Indicate Patients Who Would Benefit from CABG or PCI

The latest update of the appropriate use criteria (AUC) for coronary revascularization by Patel et al. entitled “...